NASDAQ : CAI

Caris Life Sciences, Inc. — Key statistics

Healthcare · Biotechnology · United States

Last price 36.14 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 10.21B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Key statistics

Valuation

MeasureValue
Market Cap9.70B
Enterprise Value9.36B

Dates

MeasureValue
Earnings DateNov 4, 2026
Ex-Dividend Daten/a

Shares

MeasureValue
Current Share Class282.60M
Shares Outstanding282.60M
Shares Change (YoY)+559.05%
Shares Change (QoQ)+0.12%
Owned by Insiders (%)48.80%
Owned by Institutions (%)57.82%
Float134.87M

Ratios

MeasureValue
PE Ratio92.54
Forward PE123.98
PS Ratio9.80
Forward PS8.70
PB Ratio16.39
P/TBV Ratio16.95
P/FCF Ratio78.27
P/OCF Ratio57.56
PEG Ration/a

Evratios

MeasureValue
EV / Earnings89.04
EV / Sales9.46
EV / EBITDA53.79
EV / EBIT61.08
EV / FCF75.52

Financialposition

MeasureValue
Current Ratio5.53
Quick Ratio4.75
Debt / Equity0.76
Debt / EBITDA2.45
Debt / FCF3.65
Interest Coverage3.27

Financialefficiency

MeasureValue
Return on Equity (ROE)20.13%
Return on Assets (ROA)8.77%
Return on Invested Capital (ROIC)10.00%
Return on Capital Employed (ROCE)14.76%
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employee$536,081
Profits Per Employee$56,953
Employee Count1,846
Asset Turnover0.91
Inventory Turnover3.63

Taxes

MeasureValue
Income Tax-111,000
Effective Tax Raten/a

Stockprice

MeasureValue
Beta (5Y)n/a
52-Week Price Change+16.65%
50-Day Moving Average29.16
200-Day Moving Average21.58
Relative Strength Index (RSI)62.78
Average Volume (20 Days)3,617,407

Shortselling

MeasureValue
Short Interest13.59M
Short Previous Month13.89M
Short % of Shares Out4.81%
Short % of Float10.08%
Short Ratio (days to cover)2.63

Incomestatement

MeasureValue
Revenue989.61M
Gross Profit691.23M
Operating Income153.26M
Pretax Income105.02M
Net Income105.14M
EBITDA174.03M
EBIT153.26M
Earnings Per Share (EPS)$0.37

Balancesheet

MeasureValue
Cash & Cash Equivalents793.12M
Total Debt452.40M
Net Cash340.71M
Net Cash Per Share$1.21
Equity (Book Value)591.73M
Book Value Per Share2.09
Working Capital866.39M

Cashflow

MeasureValue
Operating Cash Flow168.56M
Capital Expenditures-44.60M
Depreciation & Amortization20.76M
Net Borrowing-12.95M
Free Cash Flow123.96M
FCF Per Share$0.44

Margins

MeasureValue
Gross Margin69.85%
Operating Margin15.49%
Pretax Margin10.61%
Profit Margin10.62%
EBITDA Margin17.59%
EBIT Margin15.49%
FCF Margin12.53%

Dividends

MeasureValue
Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
FCF Payout Ration/a
Buyback Yield-559.05%
Shareholder Yield-559.05%
Earnings Yield1.08%
FCF Yield1.28%

Analystforecasts

MeasureValue
Price Target$32.46
Price Target Difference-5.45%
Analyst ConsensusBuy
Analyst Count14
Revenue Growth Forecast (3Y)20.73%
EPS Growth Forecast (3Y)n/a

Stocksplits

MeasureValue
Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

MeasureValue
Altman Z-Score5.79
Piotroski F-Score5

Fairvalue

MeasureValue
Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Number
Graham Upside